SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-19-000008
Filing Date
2019-02-11
Accepted
2019-02-11 08:48:07
Documents
4
Period of Report
2019-02-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ctic-form8xkfebruary2019pr.htm 8-K 29375
2 EXHIBIT 99.1 cticfeb2019trisenoxsales.htm EX-99.1 4061
3 cticfeb2019trisenoxsales001.jpg GRAPHIC 176198
4 cticfeb2019trisenoxsales002.jpg GRAPHIC 35490
  Complete submission text file 0000891293-19-000008.txt   326418
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 19582124
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1